Humacyte, Inc. (HUMA) Social Stream
HUMACYTE INC (HUMA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering HUMACYTE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 5 | $20 | $16 | $17.8 | $2.7 | 559.26% |
| 2022-01-31 | 6 | $20 | $16 | $17.8 | $2.7 | 559.26% |
| 2022-02-01 | 6 | $20 | $12 | $16.8 | $2.7 | 522.22% |
| 2022-03-31 | 6 | $20 | $10 | $15.833 | $2.7 | 486.41% |
| 2022-05-16 | 5 | $19 | $4 | $13.8 | $2.7 | 411.11% |
| 2022-05-17 | 5 | $19 | $4 | $13 | $2.7 | 381.48% |
| 2022-08-15 | 5 | $18 | $3.5 | $9.5 | $2.7 | 251.85% |
| 2022-11-15 | 5 | $18 | $2.75 | $8.75 | $2.7 | 224.07% |
| 2022-12-19 | 4 | $18 | $2.75 | $8.15 | $2.7 | 201.85% |
| 2023-03-24 | 5 | $18 | $2.75 | $8.15 | $2.7 | 201.85% |
| 2023-05-15 | 5 | $16 | $2.75 | $7.75 | $2.7 | 187.04% |
| 2023-06-22 | 6 | $16 | $2.75 | $6.95 | $2.7 | 157.41% |
| 2023-08-15 | 5 | $16 | $3.5 | $7.1 | $2.7 | 162.96% |
| 2023-09-13 | 6 | $16 | $3.5 | $7.3 | $2.7 | 170.37% |
| 2023-11-10 | 6 | $16 | $3 | $7.2 | $2.7 | 166.67% |
| 2023-12-11 | 7 | $16 | $3 | $7 | $2.7 | 159.26% |
The Trend in the Analyst Price Target
Over the past 13 months, HUMA's average price target has gone down $1.75.
Over the past 37 weeks, HUMA's average upside potential has been 136.25%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-28 | 5 | 16 | 2.75 | 7.750 | 3.18 | 143.71% |
| 2023-06-22 | 6 | 16 | 2.75 | 6.950 | 2.93 | 137.2% |
| 2023-06-22 | 5 | 16 | 2.75 | 6.950 | 2.93 | 137.2% |
| 2023-06-22 | 6 | 16 | 2.75 | 7.458 | 2.93 | 154.54% |
| 2023-08-15 | 5 | 16 | 3.50 | 7.100 | 4.48 | 58.48% |
HUMA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.29 | 6 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
HUMA's average broker recommendation rating improved by 0.51 over the prior 26 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- HUMA has a lower variance in analysts' estimates than -1936.01% of all US stocks.
- In the context of all US stocks, HUMACYTE INC's upside potential (average analyst target price relative to current price) is higher than 2140.96% of them.
- In terms of how HUMACYTE INC fares relative to all US stocks, note that its average analyst price target is higher than 285.95% of that group.
- In the context of Healthcare stocks, HUMACYTE INC's number of analysts covering the stock is higher than 687.56% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HUMACYTE INC are TSHA, OPT, and TARS.
View All Top Stocks by Price Target
Make investment decisions regarding HUMA using the data that counts. Try POWR Ratings for free.